The debate over the ideal blood glucose target for type 2 diabetics continued this week in the Annals of Internal Medicine, with a group of researchers defending the current recommendations of below 7 percent.

Total adherence to the 2017 hypertension guidelines would result in about 330,000 fewer deaths each year in the U.S., according to a study published May 23 in JAMA Cardiology.

Individuals with a combination of vascular risk factors and higher levels of beta-amyloid protein in the brain may be on a speedier path of cognitive decline, suggests a study published May 21 in JAMA Neurology.

South Asians are more likely to die of atherosclerotic cardiovascular disease (ASCVD) than East Asians or people of European ancestry, according to a new scientific statement published in the American Heart Association’s journal Circulation on May 24.

A smartwatch algorithm reliably differentiated atrial fibrillation (AF) from sinus rhythm among patients scheduled for elective cardioversion, showing the technology’s potential to prevent unnecessary procedures.

An investigational transcatheter mitral valve replacement (TMVR) device helped reduce mitral regurgitation to zero or trace levels in 98.7 percent of patients, according to 30-day follow-up data from the first 100 people scheduled to be treated with Abbott’s Tendyne system.

DUBLIN and PARIS — May 24, 2018 — Investigators today unveiled clinical data from the independently run Onyx 1-Month OCT Study, which showed strong early vessel healing in a patient population that contained a high percentage of patients with complex coronary artery disease who were implanted with the Resolute Onyx(TM) DES at one-month follow-up.

Assessment of coronary physiology to guide revascularization decisions has been linked to lower adverse event rates than using angiography alone, but the adoption of techniques such as fractional flow reserve (FFR) and instantaneous wave-free ratio (iFR) continues to lag behind guideline recommendations.